Novartis opens $1 billion flu vaccine plant in USA...

Swiss pharmaceutical group Novartis has inaugurated its first large-scale flu cell culture and adjuvant manufacturing plant in the United States.

The facility, with a cost of almost $1 billion (SFr999 million), is a partnership between the Basel-based company and the US Department of Health and Human Services.

Adjuvants are additives that boost the body's response to a vaccine and lowers the dose needed. They are not licensed in the US at present because of widespread public suspicion of new vaccine ingredients. More...

Don't miss:

1. South Korea investigates Roche and Novartis...
2. Novartis to invest $1 billion in China...
3. Swiss pharma giants pay millions to US politicians...
4. Novartis boss earned nearly 40 million dollars in 2008...
5. How Big Pharma dopes and dupes...